Patients will titrate up from a base dose of a GLP-1 RA to an eventual maintenance dose, increasing the dosage after around four weeks at each stop, depending on any adverse effects that may arise
Mycotoxins (toxins from mould) are some of the most prevalent toxins in our environment
Challenges in the GLP-1 Obesity Treatment Landscape Access and Affordability: High costs of GLP-1 drugs limit accessibility for many patients
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and decreased appetite
MC1R activation can also promote macrophage cholesterol efflux via ABCA1/ABCG1 and confer neuroprotective effects through cAMP/PKA/Nurr1 signaling, illustrating broader antiinflammatory and tissueprotective roles beyond pigmentation
Employer-Sponsored Plans Some Kansas employers, particularly large employers in Wichita (aviation sector), Topeka (state government), and the Kansas City metro, have added anti-obesity medications to their formularies